Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Genetics and Molecular Research

• Publication date

  2015-12-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.4238/2015.December.14.17PMID 26681036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79.

  2007cited by this paper
• White Blood Cell DNA Adducts , Smoking , and NAT 2 and GSTM 1 Genotypes in Bladder Cancer : A Case-Control Study ’

  2005cited by this paper
• Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer

  2004cited by this paper
• Genetics and the common cancers.

  2001cited by this paper
• NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.

  2000cited by this paper
• Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case‐control studies

  2000cited by this paper
• Localization of N-acetyltransferases NAT1 and NAT2 in human tissues.

  2000influential reference
• Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study.

  1999cited by this paper
• Polymorphic NATs and cancer predisposition.

  1999cited by this paper
• Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer

  1999cited by this paper
• Relationship between Schistosomiasis and Bladder Cancer

  1999cited by this paper
• White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study.

  1998cited by this paper
• Genotyping of the polymorphic N‐acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients

  1998cited by this paper
• The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.

  1998cited by this paper
• Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.

  1997cited by this paper
• Scientific Basis of Health Services

  1996cited by this paper
• Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder.

  1996cited by this paper
• Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.

  1996cited by this paper
• Metabolic polymorphisms and cancer susceptibility.

  1995cited by this paper
• Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.

  1995cited by this paper
• Invited commentary: a critical look at some popular meta-analytic methods.

  1994cited by this paper
• N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.

  1993cited by this paper
• Meta-analysis: state-of-the-science.

  1992cited by this paper
• Genetic predisposition to cancer.

  1991cited by this paper
• Acetylation phenotypes and bladder cancer.

  1990cited by this paper
• Design and conduct of occupational epidemiology studies: IV. The analysis of case-control data.

  1989cited by this paper
• Long-term followup of 103 patients with bladder exstrophy.

  1988influential reference
• Meta-analyses of randomized controlled trials.

  1987cited by this paper
• Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.

  1987cited by this paper
• N-Acetyltransferase Phenotype of Patients with Bladder Cancer

  1986cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Hepatic acetylator phenotype in bladder cancer patients.

  1985cited by this paper
• Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population.

  1985cited by this paper
• N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population.

  1985cited by this paper
• Acetylator phenotype in human bladder cancer.

  1983cited by this paper
• Cancer incidence in England and Wales

  1983cited by this paper
• The association of the slow acetylator phenotype with bladder cancer.

  1983cited by this paper
• N-Acetylation Phenotype in Bladder Cancer

  1982cited by this paper
• Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines.

  1980cited by this paper
• A simple approximation for calculating sample sizes for comparing independent proportions.

  1980cited by this paper
• N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark

  1979cited by this paper

• Human N-acetyltransferase 2 (NAT2) gene variability in Brazilian populations from different geographical areas

  2023cites this paper
• Bladder cancer

  2020cites this paper
• Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer

  2019cites this paper
• Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population

  2017influential citation
• New Progress of Epigenetic Biomarkers in Urological Cancer

  2016cites this paper